TABLE 5.12

 

Selected Epidemiologic Studies—Adult Leukemia and Exposure to Insecticides

 

138

TABLE 5.13

 

Selected Epidemiologic Studies—Childhood Leukemia and Exposure to Insecticides

 

145

TABLE 5.14

 

Selected Epidemiologic Studies—Other Childhood Cancers and Exposure to Insecticides

 

146

TABLE 6.1

 

Description of Cohort Studies Related to Exposure to Organic Solvents

 

160

TABLE 6.2

 

Description of Case-Control Studies of Oral, Nasal, and Laryngeal Cancer and Exposure to Organic Solvents

 

180

TABLE 6.3

 

Selected Epidemiologic Studies—Oral Cancer and Exposure to Organic Solvents

 

181

TABLE 6.4

 

Selected Epidemiologic Studies—Nasal Cancer and Exposure to Organic Solvents

 

182

TABLE 6.5

 

Selected Epidemiologic Studies—Laryngeal Cancer and Exposure to Organic Solvents

 

183

TABLE 6.6

 

Description of Case-Control Studies of Gastrointestinal Tract Tumors and Exposure to Organic Solvents

 

185

TABLE 6.7

 

Selected Epidemiologic Studies—Esophageal Cancer and Exposure to Organic Solvents

 

189

TABLE 6.8

 

Selected Epidemiologic Studies—Stomach Cancer and Exposure to Organic Solvents

 

193

TABLE 6.9

 

Selected Epidemiologic Studies—Colon Cancer and Exposure to Organic Solvents

 

197

TABLE 6.10

 

Selected Epidemiologic Studies—Rectal Cancer and Exposure to Organic Solvents

 

202

TABLE 6.11

 

Selected Epidemiologic Studies—Pancreatic Cancer and Exposure to Organic Solvents

 

205

TABLE 6.12

 

Description of Case-Control Studies of Liver Cancer and Exposure to Organic Solvents

 

208

TABLE 6.13

 

Selected Epidemiologic Studies—Hepatobiliary Cancers and Exposure to Organic Solvents

 

211

TABLE 6.14

 

Description of Case-Control Studies of Lung Cancer and Exposure to Organic Solvents

 

215

TABLE 6.15

 

Selected Epidemiologic Studies—Lung Cancer and Exposure to Organic Solvents

 

219

TABLE 6.16

 

Selected Epidemiologic Studies—Bone Cancer and Exposure to Organic Solvents

 

225

TABLE 6.17

 

Description of Case-Control Studies of Melanoma Skin Cancers and Exposure to Organic Solvents

 

227

TABLE 6.18

 

Selected Epidemiologic Studies—Melanoma Skin Cancers and Exposure to Organic Solvents

 

228

TABLE 6.19

 

Selected Epidemiologic Studies—Nonmelanoma Skin Cancers and Exposure to Organic Solvents

 

229

TABLE 6.20

 

Description of Case-Control Studies of Breast Cancer and Exposure to Organic Solvents

 

231

TABLE 6.21

 

Selected Epidemiologic Studies—Breast Cancer and Exposure to Organic Solvents

 

234

TABLE 6.22

 

Selected Epidemiologic Studies—Cervical Cancer and Exposure to Organic Solvents

 

239

TABLE 6.23

 

Selected Epidemiologic Studies—Ovarian Cancer and Exposure to Organic Solvents

 

240

TABLE 6.24

 

Selected Epidemiologic Studies—Uterine and Endometrial Cancer and Exposure to Organic Solvents

 

241

TABLE 6.25

 

Description of Case-Control Study of Prostate Cancer and Exposure to Organic Solvents

 

242

TABLE 6.26

 

Selected Epidemiologic Studies—Prostate Cancer and Exposure to Organic Solvents

 

244

TABLE 6.27

 

Description of Case-Control Studies of Bladder Cancer and Exposure to Organic Solvents

 

248

TABLE 6.28

 

Selected Epidemiologic Studies—Bladder Cancer and Exposure to Organic Solvents

 

254

TABLE 6.29

 

Description of Case-Control Studies of Kidney Cancer and Exposure to Organic Solvents

 

260

TABLE 6.30

 

Selected Epidemiologic Studies—Kidney Cancer and Exposure to Organic Solvents

 

267

TABLE 6.31

 

Description of Case-Control Studies of Brain and Central Nervous System Cancers and Exposure to Organic Solvents

 

273

TABLE 6.32

 

Selected Epidemiologic Studies—Brain and Central Nervous System Tumors and Exposure to Organic Solvents

 

277

TABLE 6.33

 

Description of Case-Control Studies of Non-Hodgkin’s Lymphoma and Exposure to Organic Solvents

 

284

TABLE 6.34

 

Selected Epidemiologic Studies—Non-Hodgkin’s Lymphoma and Exposure to Organic Solvents

 

290

TABLE 6.35

 

Description of Case-Control Studies of Hodgkin’s Disease and Exposure to Organic Solvents

 

298

TABLE 6.36

 

Selected Epidemiologic Studies—Hodgkin’s Disease and Exposure to Organic Solvents

 

299

TABLE 6.37

 

Description of Case-Control Studies of Multiple Myeloma and Exposure to Organic Solvents

 

302

TABLE 6.38

 

Selected Epidemiologic Studies—Multiple Myeloma and Exposures to Organic Solvents

 

304

TABLE 6.39

 

Description of Case-Control Studies of Leukemia and Exposure to Organic Solvents

 

309

TABLE 6.40

 

Selected Epidemiologic Studies—Adult Leukemia and Exposure to Organic Solvents

 

315

TABLE 6.41

 

Selected Epidemiologic Studies—Acute Leukemia and Exposure to Organic Solvents

 

320

TABLE 6.42

 

Selected Epidemiologic Studies—Chronic Leukemia and Exposure to Organic Solvents

 

323

TABLE 6.43

 

Selected Epidemiologic Studies—Lymphatic Leukemia and Exposure to Organic Solvents

 

324

TABLE 6.44

 

Selected Epidemiologic Studies—Hairy Cell Leukemia and Exposure to Organic Solvents

 

325

TABLE 6.45

 

Description of Case-Control Studies of Myelodysplastic Syndromes and Exposure to Organic Solvents

 

328

TABLE 6.46

 

Selected Epidemiologic Studies—Myelodysplastic Syndromes and Exposure to Organic Solvents

 

330



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement